Escitalopram Oxalate, 128196-01-0 API Manufacturers&Suppliers in India

Escitalopram Oxalate, 128196-01-0 API Manufacturers & Suppliers in India

Escitalopram Oxalate (CAS No. 128196-01-0) is a widely used selective serotonin reuptake inhibitor (SSRI), primarily prescribed for the treatment of major depressive disorder (MDD) and generalized anxiety disorder (GAD). As an active pharmaceutical ingredient (API), Escitalopram Oxalate plays a crucial role in managing mental health conditions by increasing serotonin levels in the brain, which help improve mood, reduce anxiety, and stabilize emotions.


The Indian pharmaceutical industry is a significant player in the production of high-quality Escitalopram Oxalate APIs, thanks to its robust manufacturing infrastructure, highly skilled workforce, and stringent adherence to international standards. Companies like KekulePharma have emerged as leaders in the manufacture and supply of Escitalopram Oxalate API, with an emphasis on delivering highly potent and complex, semi-synthetic APIs. These companies are also committed to providing cost-effective, high-quality APIs for both domestic and global markets.

This article will explore Escitalopram Oxalate API, its uses, the manufacturing process, the key manufacturers and suppliers in India, and the factors that have made India a hub for the production of Escitalopram Oxalate and other complex APIs.

What is Escitalopram Oxalate?


Chemical Composition and Structure


Escitalopram Oxalate is the oxalate salt form of Escitalopram, which itself is the S-enantiomer of Citalopram, a well-known SSRI. Its chemical structure consists of a benzene ring with a phenylmethyl group attached, and a piperazine ring containing nitrogen. The molecular formula of Escitalopram Oxalate is C20H21FN2O·C2H2O4, and its molecular weight is approximately 414.42 g/mol.

The key component of Escitalopram Oxalate’s chemical structure is its ability to inhibit the reuptake of serotonin in the brain, thereby improving mood and reducing anxiety.

Mechanism of Action


Escitalopram Oxalate works by inhibiting the serotonin transporter (SERT), which is responsible for the reabsorption of serotonin from the synaptic cleft into the presynaptic neuron. By inhibiting this reuptake, Escitalopram Oxalate increases the concentration of serotonin in the synaptic gap, thereby enhancing serotonergic neurotransmission. This action helps alleviate symptoms of depression and anxiety by improving mood, enhancing emotional stability, and reducing feelings of sadness or tension.

The therapeutic effects of Escitalopram Oxalate are believed to result from increased serotonergic activity in brain regions associated with mood regulation, such as the limbic system and cortex.

Medical Uses of Escitalopram Oxalate


Escitalopram Oxalate is primarily used to treat various mental health conditions, including:

  1. Major Depressive Disorder (MDD): Escitalopram Oxalate is commonly prescribed for individuals suffering from major depressive disorder. It helps improve mood, reduce feelings of worthlessness, and alleviate symptoms like insomnia, poor concentration, and lack of energy.

  2. Generalized Anxiety Disorder (GAD): Escitalopram is effective in treating generalized anxiety disorder, characterized by excessive worry and restlessness.

  3. Obsessive-Compulsive Disorder (OCD): Escitalopram Oxalate is used off-label in some cases to treat obsessive-compulsive disorder, helping patients reduce unwanted intrusive thoughts and repetitive behaviors.

  4. Panic Disorder: Escitalopram can also be prescribed to help manage panic disorder, characterized by sudden and recurrent panic attacks.

  5. Social Anxiety Disorder: Escitalopram has shown efficacy in reducing social anxiety and improving the ability to engage in social interactions.

  6. Post-Traumatic Stress Disorder (PTSD): In some cases, Escitalopram Oxalate may be used to treat post-traumatic stress disorder by reducing anxiety and intrusive memories related to traumatic events.


Dosage and Administration


Escitalopram Oxalate is available in oral tablet and oral solution forms. The dosage of Escitalopram Oxalate depends on the condition being treated and the patient's individual response:

  • Starting Dose: Typically, a 10 mg dose is prescribed once daily.

  • Maintenance Dose: The dosage may be increased gradually, with a usual maximum dose of 20 mg per day.

  • Elderly or Renally Impaired Patients: A lower starting dose of 5 mg may be recommended to avoid the risk of side effects.


It is important for patients to follow their healthcare provider’s instructions carefully and not to stop or adjust the dosage without consulting a doctor, as sudden changes can lead to withdrawal symptoms or relapse.

Manufacturing of Escitalopram Oxalate API in India


India is one of the world's largest producers of pharmaceutical APIs, including Escitalopram Oxalate. The manufacturing of Escitalopram Oxalate involves a multi-step synthesis process, combining sophisticated chemical techniques with stringent quality control to ensure the final product meets the required standards.

The Synthesis Process of Escitalopram Oxalate API


The production of Escitalopram Oxalate API involves the following steps:

  1. Synthesis of Precursors: The first step in the synthesis of Escitalopram Oxalate involves the preparation of Citalopram or its precursor compounds. This process requires specialized reagents and conditions to control the stereochemistry and ensure the desired S-enantiomer is produced.

  2. Formation of Escitalopram: Once Citalopram is synthesized, the conversion to Escitalopram (the S-enantiomer) is achieved via a chemical process that separates the desired enantiomer from its racemic mixture. The S-enantiomer is the pharmacologically active component of the drug.

  3. Oxalate Salt Formation: Escitalopram is then reacted with oxalic acid to form Escitalopram Oxalate, which is more stable and easier to handle than the free base.

  4. Purification: The Escitalopram Oxalate API undergoes extensive purification through processes such as recrystallization and chromatography to ensure the product meets the required purity and quality standards.

  5. Quality Control and Testing: After the synthesis and purification processes, the API undergoes a series of rigorous quality control tests, including HPLC (high-performance liquid chromatography), melting point determination, assay, and stability studies. These tests are conducted to ensure that the final product is safe, effective, and free from impurities.

  6. Packaging and Distribution: The final Escitalopram Oxalate API is then packaged in compliant containers to prevent contamination and preserve the quality of the API during transportation and storage.


Challenges in Manufacturing Escitalopram Oxalate


The synthesis of Escitalopram Oxalate presents several challenges:

  • Enantiomeric Purity: Ensuring the production of the S-enantiomer of Citalopram is crucial, as only this enantiomer exhibits the desired therapeutic effects. This requires careful control during the synthesis process.

  • Chemical Synthesis: The synthesis of Escitalopram and its oxalate salt requires advanced organic chemistry techniques to achieve high yields and purity.

  • Regulatory Compliance: As with all pharmaceutical APIs, Escitalopram Oxalate API must meet stringent regulatory requirements, including compliance with Good Manufacturing Practices (GMP) and ICH guidelines. Manufacturers must also obtain certifications from regulatory bodies like the FDA (Food and Drug Administration) and the EMA (European Medicines Agency).

  • Environmental Considerations: The production of pharmaceutical APIs requires the careful management of waste products and by-products, including solvents and chemical residues.


Regulatory Compliance


Indian pharmaceutical manufacturers adhere to global regulatory standards, ensuring that their Escitalopram Oxalate API is of the highest quality. Regulatory bodies like the FDA, EMA, and WHO set strict standards for API manufacturing, which companies in India follow to ensure compliance with international laws. ISO certifications, GMP guidelines, and drug master files (DMFs) are essential for Indian manufacturers to maintain their status as suppliers of high-quality APIs to global markets.

Leading Escitalopram Oxalate API Manufacturers and Suppliers in India


India has several prominent pharmaceutical companies that manufacture Escitalopram Oxalate API. These companies are recognized for their high-quality standards, innovation in manufacturing techniques, and efficient supply chain management. Some of the top Escitalopram Oxalate API manufacturers in India include:

KekulePharma


KekulePharma is a leading manufacturer and supplier of Escitalopram Oxalate API in India. Known for its advanced manufacturing techniques and high-quality products, KekulePharma focuses on semi-synthetic APIs and follows stringent quality controls to meet international standards.

Aurobindo Pharma


Aurobindo Pharma is one of India's largest pharmaceutical companies and a well-known manufacturer of Escitalopram Oxalate. The company operates state-of-the-art manufacturing facilities and is known for producing high-quality APIs at competitive prices.

Sun Pharmaceutical Industries


Sun Pharma is a global leader in the pharmaceutical industry, offering a wide range of APIs, including Escitalopram Oxalate. Sun Pharma’s global supply chain network ensures timely delivery of APIs to customers worldwide.

Dr. Reddy’s Laboratories


Dr. Reddy’s Laboratories is another major player in the Indian pharmaceutical industry, manufacturing Escitalopram Oxalate API and other mental health-related medications. Dr. Reddy’s commitment to quality assurance and innovation makes it a trusted supplier.

Lupin Pharmaceuticals


Lupin Pharmaceuticals manufactures a wide range of antidepressant APIs, including Escitalopram Oxalate, and has a strong international presence.

Why India is the Preferred Destination for Escitalopram Oxalate API Production


India has become a leading destination for the production of Escitalopram Oxalate API due to several factors:

1. Cost-Effective Manufacturing


India’s cost advantages in labor, raw materials, and overheads make it an attractive hub for API manufacturing. Indian companies can produce high-quality APIs at a fraction of the cost compared to other countries.

2. Expertise in Chemistry


India boasts a highly skilled workforce with expertise in organic chemistry, enabling the efficient synthesis of complex compounds like Escitalopram Oxalate.

3. Regulatory Compliance


Indian manufacturers adhere to international regulatory standards, ensuring their products are accepted in global markets.

4. Strong Export Network


India’s well-established pharmaceutical supply chain network allows for the seamless export of Escitalopram Oxalate API to over 150 countries, including the United States, Europe, and emerging markets.

5. Focus on R&D


Many Indian pharmaceutical companies invest heavily in research and development (R&D), enabling them to develop more efficient and cost-effective manufacturing processes for APIs like Escitalopram Oxalate.

India has become a global leader in the production of high-quality Escitalopram Oxalate API, driven by its cost-effective manufacturing processes, skilled workforce, regulatory compliance, and innovation in pharmaceutical production. Companies like KekulePharma, Aurobindo Pharma, and Dr. Reddy’s Laboratories are at the forefront of manufacturing and supplying Escitalopram Oxalate to pharmaceutical companies worldwide. As the demand for mental health medications continues to grow, India remains an indispensable hub for the production and supply of Escitalopram Oxalate API.

Leave a Reply

Your email address will not be published. Required fields are marked *